Your Article Summary
PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard in The U.S.
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/01/08
PLC Systems Inc. announced that it has received full approval from the U.S. Food and Drug Administration (FDA) for its U.S. pivotal trial to study the effectiveness of the Company's RenalGuard System and associated therapy in the prevention of Contrast-Induced Nephropathy (CIN).
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Recombinant Human Erythropoietin, Epogin Injection
Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
Article Search
Sponsor


See Latest Articles


